Jan Schrooten

Jan Schrooten

Jan Schrooten

Co-Founder & CEO - Antleron

Dr.ir. Jan Schrooten is co-founder and CEO of Antleron, a young R&D company on a mission to enable personalized manufacturing 4.0 in the domain of advanced therapies. The core concept of Antleron’s innovation is integrating 3D printing, engineered cell-production processes in bioreactors and digital process control & optimization into factories-of-the-future for cell therapy, vaccine and tissue manufacturing.

Jan Schrooten is board member of flanders.bio, the cluster organisation for the life sciences sector in Flanders.


Previously Jan Schrooten was senior research manager at KU Leuven (Belgium), responsible for the long-term management and technology transfer of biomaterials and tissue engineering research. Trained as a materials engineer, with an engineering PhD in biomaterials and a postgraduate in business administration, he has 25+ years of research experience in biomaterials and tissue engineering. He also co-founded and managed for 8 years Prometheus, the KU Leuven R&D division of Skeletal Tissue Engineering.


Scientifically he focused on translational regenerative medicine, with special attention for tissue engineering applications. His work has been disseminated in 180+ peer reviewed international journal publications and conference proceedings (h-index of 41). He was (co)promotor of 15+ PhD researchers. He was a visiting research fellow at the University of New South Wales (Australia) and the Ecole Polytechnique Fédérale de Lausanne (Switzerland).

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners